Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) dropped 5.5% during trading on Tuesday . The company traded as low as $0.58 and last traded at $0.58. Approximately 795,381 shares were traded during mid-day trading, a decline of 36% from the average daily volume of 1,235,559 shares. The stock had previously closed at $0.62.
Elite Pharmaceuticals Stock Down 0.4%
The company has a quick ratio of 3.50, a current ratio of 4.88 and a debt-to-equity ratio of 0.08. The firm's 50 day simple moving average is $0.58 and its two-hundred day simple moving average is $0.51.
Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) last released its earnings results on Monday, June 30th. The specialty pharmaceutical company reported $0.01 EPS for the quarter. Elite Pharmaceuticals had a negative net margin of 5.13% and a positive return on equity of 3.96%. The firm had revenue of $32.00 million for the quarter.
About Elite Pharmaceuticals
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Read More
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
